Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](LEO Pharma)"
Count: 260
Selected: 0
| NCT ID | Title |
|---|
| NCT01320774 | Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris | ||
| NCT05508776 | A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People | ||
| NCT05486117 | Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema | ||
| NCT05470114 | A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD | ||
| NCT05388760 | Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) | ||
| NCT05355818 | Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema | ||
| NCT05332366 | A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia | ||
| NCT05259722 | A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema | ||
| NCT05194540 | Tralokinumab Administered With Device A in Adults and Adolescents With Moderate-to-severe Atopic Dermatitis | ||
| NCT05117060 | Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis | ||
| NCT05099133 | A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects | ||
| NCT05050279 | A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People | ||
| NCT04949841 | Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials | ||
| NCT04922021 | An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis. | ||
| NCT04883333 | A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults | ||
| NCT04872101 | Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) | ||
| NCT04871711 | Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema | ||
| NCT04853992 | Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria | ||
| NCT04807751 | Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream | ||
| NCT04674826 | A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects | ||
| NCT04587453 | Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis | ||
| NCT04533737 | Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab | ||
| NCT04361136 | Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream | ||
| NCT04306315 | Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight | ||
| NCT04305327 | Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis | ||
| NCT04203836 | A Trial to Evaluate the Effect of Food on LEO 152020 | ||
| NCT04202445 | TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction | ||
| NCT03995550 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese | ||
| NCT03958955 | Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. | ||
| NCT03898583 | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis. | ||
| NCT03826901 | Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children | ||
| NCT03812198 | A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People | ||
| NCT03806790 | Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris | ||
| NCT03788863 | A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis | ||
| NCT03761537 | Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 | ||
| NCT03725722 | Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis. | ||
| NCT03710044 | Investigation of Flare and Remission in Subjects With Atopic Dermatitis | ||
| NCT03683719 | Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema | ||
| NCT03673527 | Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin | ||
| NCT03669757 | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis | ||
| NCT03587805 | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND | ||
| NCT03562377 | Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) | ||
| NCT03556592 | Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 | ||
| NCT03526861 | Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). | ||
| NCT03514511 | Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis | ||
| NCT03476746 | Dermatopharmacokinetic Trial of LEO 90100 Foam | ||
| NCT03442244 | Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects | ||
| NCT03402828 | Body PSOriasis: Long-term Relapse CONTROL | ||
| NCT03395132 | Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema | ||
| NCT03363854 | Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 |
